Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

PURPOSE: We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy (CSRT) to patients with high-risk medulloblastomas (MBs) and supratentorial primitive neuroectodermal tumors, and we report the outcome in the subset with metastatic (M+) MB....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Oncol
Asıl Yazarlar: Jakacki, Regina I., Burger, Peter C., Zhou, Tianni, Holmes, Emiko J., Kocak, Mehmet, Onar, Arzu, Goldwein, Joel, Mehta, Minesh, Packer, Roger J., Tarbell, Nancy, Fitz, Charles, Vezina, Gilbert, Hilden, Joanne, Pollack, Ian F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2012
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559602/
https://ncbi.nlm.nih.gov/pubmed/22665539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.40.2792
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller